Maeda H - Search Results

1

Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer.

Achiwa H, Oguri T, Sato S, Maeda H, Niimi T, Ueda R. Achiwa H, et al. Among authors: maeda h. Cancer Sci. 2004 Sep;95(9):753-7. doi: 10.1111/j.1349-7006.2004.tb03257.x. Cancer Sci. 2004. PMID: 15471562 Free PMC article.

2

p185(HER-2/neu) and p21(CIP1/WAF1) expression in primary tumors and lymph node metastases in non-small cell lung cancer.

Akita K, Inagaki H, Sato S, Niimi T, Maeda H, Ninomiya S, Achiwa H, Kawaguchi H, Yamakawa Y, Fujii Y, Shimizu S, Eimoto T, Ueda R. Akita K, et al. Among authors: maeda h. Jpn J Cancer Res. 2002 Sep;93(9):1007-11. doi: 10.1111/j.1349-7006.2002.tb02477.x. Jpn J Cancer Res. 2002. PMID: 12359054 Free PMC article.

3

Analysis of beta-tubulin gene alteration in human lung cancer cell lines.

Achiwa H, Sato S, Shimizu S, Maeda H, Niimi T, Takahashi T, Ueda R, Mitsudomi T. Achiwa H, et al. Among authors: maeda h. Cancer Lett. 2003 Nov 25;201(2):211-6. doi: 10.1016/s0304-3835(03)00473-7. Cancer Lett. 2003. PMID: 14607336

4

The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells.

Oguri T, Achiwa H, Bessho Y, Muramatsu H, Maeda H, Niimi T, Sato S, Ueda R. Oguri T, et al. Among authors: maeda h. Lung Cancer. 2005 Sep;49(3):345-51. doi: 10.1016/j.lungcan.2005.05.003. Lung Cancer. 2005. PMID: 15993511

5

Role of ABCG2 as a biomarker for predicting resistance to CPT-11/SN-38 in lung cancer.

Bessho Y, Oguri T, Achiwa H, Muramatsu H, Maeda H, Niimi T, Sato S, Ueda R. Bessho Y, et al. Among authors: maeda h. Cancer Sci. 2006 Mar;97(3):192-8. doi: 10.1111/j.1349-7006.2006.00164.x. Cancer Sci. 2006. PMID: 16542215 Free PMC article.

6

The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity.

Oguri T, Achiwa H, Sato S, Bessho Y, Takano Y, Miyazaki M, Muramatsu H, Maeda H, Niimi T, Ueda R. Oguri T, et al. Among authors: maeda h. Mol Cancer Ther. 2006 Jul;5(7):1800-6. doi: 10.1158/1535-7163.MCT-06-0025. Mol Cancer Ther. 2006. PMID: 16891466

7

MRP8/ABCC11 directly confers resistance to 5-fluorouracil.

Oguri T, Bessho Y, Achiwa H, Ozasa H, Maeno K, Maeda H, Sato S, Ueda R. Oguri T, et al. Among authors: maeda h. Mol Cancer Ther. 2007 Jan;6(1):122-7. doi: 10.1158/1535-7163.MCT-06-0529. Mol Cancer Ther. 2007. PMID: 17237272

8

MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.

Oguri T, Ozasa H, Uemura T, Bessho Y, Miyazaki M, Maeno K, Maeda H, Sato S, Ueda R. Oguri T, et al. Among authors: maeda h. Mol Cancer Ther. 2008 May;7(5):1150-5. doi: 10.1158/1535-7163.MCT-07-2088. Epub 2008 Apr 29. Mol Cancer Ther. 2008. PMID: 18445659

9

Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients.

Ninomiya S, Niimi T, Shimizu S, Sato S, Achiwa H, Ito H, Akita K, Maeda H, Ueda R. Ninomiya S, et al. Among authors: maeda h. Sarcoidosis Vasc Diffuse Lung Dis. 2004 Mar;21(1):19-24. doi: 10.1007/s11083-004-3344-x. Sarcoidosis Vasc Diffuse Lung Dis. 2004. PMID: 15127970

10

Efficacy of docetaxel as a second-line chemotherapy for thymic carcinoma.

Oguri T, Achiwa H, Kato D, Maeda H, Niimi T, Sato S, Ueda R. Oguri T, et al. Among authors: maeda h. Chemotherapy. 2004 Dec;50(6):279-82. doi: 10.1159/000082626. Epub 2004 Dec 8. Chemotherapy. 2004. PMID: 15608443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,032 results

Search Page

Filters